Overview
Vesugen is a synthetic tripeptide bioregulator (Lys-Glu-Asp) developed by Vladimir Khavinson’s research group at the St. Petersburg Institute of Bioregulation and Gerontology. It is associated with vascular tissue regulation and has been studied for its effects on endothelial function, blood vessel integrity, and age-related vascular decline. FenaLife supplies Vesugen in lyophilized form for research use only.
Research Background
Vesugen is part of the Khavinson bioregulator peptide program, which proposes that short peptides derived from tissue-specific organ extracts act as gene regulators for those tissues. Vesugen’s vascular association places it in the category of endothelial and circulatory tissue bioregulators. Animal studies from the Khavinson group have documented effects on vascular reactivity and endothelial cell function in aged animal models.
Studied Mechanisms
Following the bioregulator framework, Vesugen is proposed to interact with chromatin in vascular endothelial cells to support tissue-appropriate gene expression. Research has examined effects on nitric oxide production, inflammatory cytokine expression in vascular tissue, and structural parameters of blood vessel walls in aging models.
Molecular Profile
Molecular formula: C15H25N5O9. Molecular weight: 423.39 g/mol. Stable tripeptide with favorable handling characteristics. Purity: ≥98% by HPLC.
Storage and Handling
Store lyophilized Vesugen at -20°C. Reconstitute with bacteriostatic water. Store reconstituted solution at 4°C and use within 4 to 6 weeks.
Research Use Only
For laboratory research purposes only. Not for human or veterinary use. Certificate of Analysis available per batch.